Browsing Category

65916 posts
Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment

Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment

FDA IND Clearance for CBL-0201WR—Caliway has cleared its Investigational New Drug application…

Founder Securities Chief Economist Yan Xiang: China's Capital Market Is Better Aligned and More Effective in Backing the New Growth Drivers

BEIJING, Aug. 26, 2026 /PRNewswire/ — The Political Bureau of the CPC…
Agoda and NTT DATA Advance Renewable Energy and Data Center Efficiency in Singapore

Agoda and NTT DATA Advance Renewable Energy and Data Center Efficiency in Singapore

SINGAPORE, Aug. 26, 2026 /PRNewswire/ — Digital travel platform Agoda today announced…

Joyson Electronics Announces H1 2026 Results: Net Profit Attributable to Shareholders of RMB 740 Million

Accelerating Breakthroughs in Emerging Technology Business HONG KONG, Aug. 25, 2026 /PRNewswire/…
Gen Precision Launches Automated DIMM Final Test System GTK-SPT1 for Unattended DRAM Module Testing

Gen Precision Launches Automated DIMM Final Test System GTK-SPT1 for Unattended DRAM Module Testing

Gen Precision’s GTK-SPT1 automates DDR4 and DDR5 DIMM final testing and burn-in,…
Handshakes Launches AI Agent to Transform Corporate Due Diligence and Investigation

Handshakes Launches AI Agent to Transform Corporate Due Diligence and Investigation

Drawing on decades of regulatory expertise, the beta AI-powered agent runs due…

HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell

KEY POINTS First patient safely dosed in Phase 1 KOALA trial evaluating…

Symbos Receives Frost & Sullivan's 2026 Australian Transformational Innovation Leadership Recognition for its Customer Experience Management Services

The company is setting a new benchmark in Australian CXM through outcome-focused…